75 related articles for article (PubMed ID: 1995314)
1. Direct morphological evidence of high-dose methylprednisolone-induced maturation of leukemic cells in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S; Tuncer AM; Ertürk G; Ozbek N; Karadeniz N
Exp Hematol; 1991 Mar; 19(3):232-3. PubMed ID: 1995314
[No Abstract] [Full Text] [Related]
2. The effect of steroid on myeloid leukemic cells: the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis.
Hiçsönmez G
Leuk Res; 2006 Jan; 30(1):60-8. PubMed ID: 15979702
[TBL] [Abstract][Full Text] [Related]
3. High-dose methylprednisolone for acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S
Exp Hematol; 1989 Nov; 17(10):1051-2. PubMed ID: 2806437
[No Abstract] [Full Text] [Related]
4. The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor.
Hiçsönmez G; Cetin M; Aslan D; Ozyürek E
Pediatr Hematol Oncol; 2003; 20(5):373-9. PubMed ID: 12775535
[TBL] [Abstract][Full Text] [Related]
5. The potential role of high-dose methylprednisolone on the maturation of leukemic cells in children with acute promyelocytic leukemia (APL).
Hiçsönmez G; Tuncer AM; Güler E; Tan E; Tekelioglu M
Exp Hematol; 1993 May; 21(5):599-601. PubMed ID: 8513858
[No Abstract] [Full Text] [Related]
6. Effects of methylprednisolone on human myeloid leukemic cells in vitro.
Ozbek N; Erdemli E; Hiçsönmez G; Okur H; Tekelioğlu M
Am J Hematol; 1999 Apr; 60(4):255-9. PubMed ID: 10203097
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission.
Abrahm JL; Gerson SL; Hoxie JA; Tannenbaum SH; Cassileth PA; Cooper RA
Cancer Res; 1986 Jul; 46(7):3711-6. PubMed ID: 3518922
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
Brodzki LM
Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
[No Abstract] [Full Text] [Related]
9. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia.
Yildiran A; Erduran E; Tekelioğlu Y; Dilber E; Gedik Y
Turk J Pediatr; 2002; 44(2):116-21. PubMed ID: 12026198
[TBL] [Abstract][Full Text] [Related]
10. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
11. Terminal differentiation of human leukemic blasts in response to 12-0-tetradecanoyl-13-phorbol acetate (TPA).
Joshi KS; Rao SG; Joshi DS; Advani SH; Bhisey AN
Anticancer Res; 1988; 8(6):1367-71. PubMed ID: 3218970
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of myeloid leukemic cells induced by high-dose methylprednisolone in patients with acute myeloblastic leukemia and its therapeutic potential.
Hicsonmez G; Ozsoylu S; Tuncer AM
Leuk Res; 1991; 15(7):537-41. PubMed ID: 1861537
[No Abstract] [Full Text] [Related]
13. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers.
Chen ZX; Wang W; Wu WL
Chin Med J (Engl); 1989 Mar; 102(3):174-82. PubMed ID: 2503303
[TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
Marie JP; Thevenin D; Zittoun R
Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
[TBL] [Abstract][Full Text] [Related]
15. High-dose intravenous methylprednisolone in the treatment of acute nonlymphoblastic leukemia with ocular involvement.
Hiçsönmez G; Ozsoylu S; Tuncer M; Erer B
Turk J Pediatr; 1988; 30(3):181-3. PubMed ID: 3242191
[No Abstract] [Full Text] [Related]
16. Study of differentiation of fresh human leukemic cells by low dose cytosine arabinoside (LD Ara-C) and 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuliczkowski K; Noworolska A; Frydecka I; Sedek K; Harłozińska A
Neoplasma; 1989; 36(5):589-97. PubMed ID: 2812152
[TBL] [Abstract][Full Text] [Related]
17. [Modern strategies in therapy of acute myeloid leukemia (AML) in adulthood. I. Primary treatment of de novo AML].
Jehn U; Dengler R; Petrides PE
Internist (Berl); 1996 Jun; 37(6):661-8. PubMed ID: 8768003
[No Abstract] [Full Text] [Related]
18. Long-term bone marrow culture induces terminal differentiation of human myeloid leukemic cells.
Iland HJ; Croaker GM; Repka E; Radloff TJ; Vincent PC
Exp Hematol; 1987 Dec; 15(11):1109-14. PubMed ID: 3479335
[TBL] [Abstract][Full Text] [Related]
19. Circumvention of glucocorticoid resistance in childhood leukemia.
Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
Leuk Res; 2008 Sep; 32(9):1417-23. PubMed ID: 18395253
[TBL] [Abstract][Full Text] [Related]
20. High-dose methylprednisolone in children with acute nonlymphoblastic leukemia.
Hiçsönmez G; Ozsoylu S
Am J Hematol; 1990 Dec; 35(4):288-9. PubMed ID: 2239928
[No Abstract] [Full Text] [Related]
[Next] [New Search]